newsfilter
← Latest News
PR Newswire·

Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients

Removes Centralized Lab Dependency for $3.8 Billion Global Addressable Market forNETosis TestingHENDERSON, Nev., Aug. 12, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national